Expert insights. Personalized for you.
Biotechnology Related Topics 
McKinsey Public & Social Sector Insights
OCTOBER 11, 2022
Insights on Life Sciences BiotechnologyLeveraging digital and analytics advances can unlock significant value for biopharma companies through gains in quality, speed, agility, and resilience.
McKinsey
JUNE 9, 2022
Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). Insights on Life Sciences Biotechnology
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
JUNE 10, 2022
Insights on Life Sciences BiotechnologyFrom 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could transform the industry.
McKinsey Public & Social Sector Insights
OCTOBER 11, 2022
Insights on Life Sciences BiotechnologyThe recent market downturn has affected biotechs worldwide. But the fundamentals are still strong in Europe, where companies have an opportunity to lead the next phase of bioscience innovation.
McKinsey
APRIL 8, 2022
Insights on Life Sciences Biotechnology InnovationHarnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease.
McKinsey Public & Social Sector Insights
SEPTEMBER 19, 2022
Insights on Life Sciences Biotechnology Public SectorAfter a decade of plenty, biotechs are grappling with a challenging market. To emerge strongly, they can streamline R&D and G&A expenses, evaluate new financing options, and consider mergers with other biotechs.
McKinsey
MARCH 23, 2022
Insights on Life Sciences Biotechnology Globalization StrategyEstablishing an international presence with a first launch is a challenge, but learning from others’ experiences can help biotechs avoid missteps and maximize their chances of success.
McKinsey
MAY 11, 2022
Insights on Life Sciences Health Care BiotechnologyBiotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation.
McKinsey
JULY 15, 2022
Insights on Life Sciences BiotechnologyScience and technology are driving breakthroughs at each stage of the biomedical R&D value chain. Enhancing feedback loops among them could unleash a self-learning model that would benefit patients.
McKinsey Public & Social Sector Insights
AUGUST 19, 2022
Insights on Life Sciences BiotechnologyThe biosimilars market is poised to grow over the next decade. Here’s how companies can accelerate time to market, reduce R&D costs, and improve productivity.
McKinsey Public & Social Sector Insights
AUGUST 17, 2022
Future of Asia Biotechnology Pharmaceuticals Asia-PacificThe cochairman and managing director of the pharma multinational believes India’s competence in new biology, clinical development, and chemistry will increase its global competitiveness.
McKinsey
JUNE 29, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeWorld-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe is to emerge as a leader in biotech.
McKinsey
MAY 17, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals BiotechnologyViral-vector gene therapies show great promise, but the full extent of their clinical impact in the long term is not yet certain. Success depends on innovative solutions that remain under development.
McKinsey
MAY 12, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyThe leaders of Gingko Bioworks and the BIO organization discuss the future of biological technologies, from developing vaccines faster to changing how we produce food.
McKinsey
APRIL 30, 2021
Insights on Pharmaceuticals & Medical Products Venture capital BiotechnologyEven in tough times, investor expectations and deal making in biotech are surging. Can the sector maintain its strong growth?
McKinsey
JUNE 7, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology PharmaceuticalsWith rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models, rethink their portfolio management, and accelerate their R&D.
McKinsey
MAY 13, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology Pharmaceuticals Oncology/CancerThe small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.
Frost & Sullivan Manufacturing
SEPTEMBER 8, 2022
Shamsudeen added: “With biotechnological processes producing novel molecules, metal-based antimicrobials can profile efficient solutions to infection care and health. San Antonio– Sept.
Frost & Sullivan
MARCH 30, 2021
Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6
Frost & Sullivan
JULY 22, 2021
Healthcare News Press Releases biopharma biopharmaceutical biotechnology biotherapeutics COVID-19 vaccine logistics DNA drug mrna pharma Pharmaceutical research RNA therapeutics vaccine
McKinsey
JULY 29, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyWe mapped out 1,382 biotechs based in Europe and some interesting themes emerged.
McKinsey
AUGUST 5, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China.
McKinsey
AUGUST 26, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyHow can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.
Frost & Sullivan
MARCH 30, 2021
Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6
McKinsey
AUGUST 23, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential to the continued growth of this sector.
McKinsey
SEPTEMBER 15, 2021
Insights on Life Sciences BiotechnologyHow can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.
McKinsey
AUGUST 23, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation Index improved by 20 percent in 2015–17 and 2018–20.
LaVoie Health Science Blog
NOVEMBER 9, 2022
I’m looking forward to bringing impactful media solutions to our biotechnology, medical technology, pharmaceutical, and consumer wellness clients through doing what I most love to do – earning influential media placements.”.
Peter Simoons
SEPTEMBER 12, 2022
” Head of Alliance Management – Biotechnology Research Organisation. Recently we’ve noticed rising interest in alliances & partnerships. My alliance partner Anoop Nathwani and I hear it in the many conversations that we have.
Peter Simoons
AUGUST 14, 2022
It is one of the best-run online learning experiences I have attended” Head of Alliance Management – Biotechnology Research Organisation. It must have been twenty years ago that I signed up for my first course on strategic alliances.
LaVoie Health Science Blog
JANUARY 26, 2021
The “ 2021 Preview: A 360 Degree Global Market View, ” virtual webinar was designed to discuss global market trends on public and private United States, Europe, and China markets, JPM virtual week in January 2021, and more.
LaVoie Health Science Blog
AUGUST 16, 2022
Plumstead brings over 20 years of experience leading product and corporate public relations initiatives for companies in the pharmaceutical, biotechnology, and medical device sectors.
LaVoie Health Science Blog
JANUARY 7, 2021
In addition to expanding its strategic communications team, LHS also debuted its virtual webinar series with Biotechnology Innovation Organization, including a 2021 Preview: A 360-Degree Global Market View. BOSTON & NEW YORK – January 7, 2021.
LaVoie Health Science Blog
OCTOBER 5, 2020
Successful candidate will be a detail-oriented self-starter with 3-5 years of agency or related experience in healthcare in particular for biotechnology and pharmaceutical industries or technology. Join a health science focused integrated communications agency and be part of the agency’s second phase of growth. Strong detail oriented public relations/communications professional needed for growing life science/biopharmaceutical practice.
Frost & Sullivan Manufacturing
SEPTEMBER 26, 2022
The end-use industries that consume HMAs are undergoing several transformations that will influence their use. They are increasingly seeking de-bondable HMA solutions to avoid material waste, save manufacturing costs, and contribute to a reduced environmental footprint.
LaVoie Health Science Blog
NOVEMBER 16, 2021
Further Strengthens IR Leadership Team and Supports Integrated Strategic Communications Capabilities and Continued Business Growth. link].
LaVoie Health Science Blog
JULY 5, 2022
GB: Donna, you have been presenting How to Tell Your Company Story in 15 Slides at the Biotechnology Innovation Organization International Convention for many years. by Gemma Bakx, SVP, Investor Relations and ESG.
Frost & Sullivan Manufacturing
JUNE 21, 2022
DSM has a strong portfolio of bio-based ingredients that will be complemented by Firmenich’s long-standing experience in natural and biotechnology-derived ingredients. In May 2022, DSM and Firmenich announced their plans to merge together.
Frost & Sullivan
JUNE 21, 2022
DSM has a strong portfolio of bio-based ingredients that will be complemented by Firmenich’s long-standing experience in natural and biotechnology-derived ingredients. In May 2022, DSM and Firmenich announced their plans to merge together.
ClearPoint Strategy
NOVEMBER 2, 2022
Industries It Serves: Hospital & Health Care • Banking • Biotechnology • Financial Services • Automotive • Executive Offices • Government • IT and Services • Mining & Metals • Nonprofit.
92 
Let's personalize your content